Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment -- a review.
about
Alpha-2 adrenergic challenge with guanfacine one month after mild traumatic brain injury: altered working memory and BOLD responseAdrenergic pharmacology and cognition: focus on the prefrontal cortexNeurobiological consequences of traumatic brain injuryGenetics and outcomes after traumatic brain injury (TBI): what do we know about pediatric TBI?Functional MRI of mild traumatic brain injury (mTBI): progress and perspectives from the first decade of studiesLong-lasting suppression of acoustic startle response after mild traumatic brain injury.Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisDopaminergic challenge with bromocriptine one month after mild traumatic brain injury: altered working memory and BOLD responseCognitive Predictors of Medical Decision-Making Capacity in Traumatic Brain InjuryPersistent working memory dysfunction following traumatic brain injury: evidence for a time-dependent mechanism.Resting-state neuronal oscillatory correlates of working memory performance.Effects of psychological and biomechanical trauma on brain and behavior.Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study.NIH Toolbox Cognition Battery (NIHTB-CB): list sorting test to measure working memoryDisruption of caudate working memory activation in chronic blast-related traumatic brain injury.Decoding hippocampal signaling deficits after traumatic brain injuryInfluence of Catechol-O-methyltransferase on Executive Functioning Longitudinally After Early Childhood Traumatic Brain Injury: Preliminary FindingsNeurobehavioral sequelae of traumatic brain injury: evaluation and management.Prenatal exposure to bisphenol A impacts neuronal morphology in the hippocampal CA1 region in developing and aged mice.Neurocognitive enhancement: ethical considerations for an emerging subspecialty.A review of pharmacological treatments used in experimental models of traumatic brain injury.Phosphodiesterase inhibition rescues chronic cognitive deficits induced by traumatic brain injuryNeuropsychological functioning and brain structure in schizophrenia.Augmented neural activity during executive control processing following diffuse axonal injuryPolymorphisms in genes modulating the dopamine system: do they inf luence outcome and response to medication after traumatic brain injury?Psychopharmacological issues in the treatment of TBI and PTSD.Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?Association of a common genetic variant within ANKK1 with six-month cognitive performance after traumatic brain injuryDelayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.Functional assessment of immediate task planning and execution by adults with acquired brain injury.Enhancing behavioral health treatment and crisis management through mobile ecological momentary assessment and SMS messaging.Traumatic brain injury and cognitive impairment in men who are homeless.Catechol-O-Methyltransferase Genotypes and Parenting Influence on Long-Term Executive Functioning After Moderate to Severe Early Childhood Traumatic Brain Injury: An Exploratory Study.Alpha-synuclein (SNCA) polymorphisms exert protective effects on memory after mild traumatic brain injury.Normabaric Hyperoxia Treatment Improved Locomotor Activity of C57BL/6J Mice through Enhancing Dopamine Genes Following Fluid-Percussion Injury in Striatum.A perfusion fMRI study of the neural correlates of sustained-attention and working-memory deficits in chronic traumatic brain injury.The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therapeutic target in traumatic brain injury.Cholinergic enhancement of frontal lobe activity in mild cognitive impairment.Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury.Bromocriptine in traumatic brain injury.
P2860
Q24630396-7A5FDE8F-7394-4CAE-8E3E-863CC94A0164Q24684217-D5072343-C19A-4D46-8EBC-A3F6C5849020Q26852324-1D64677D-947D-461E-8A0B-83BAF3CDD073Q26866306-39965EB6-5BFD-4F7F-9F57-D09DC4A8FF83Q26997913-7C8302D2-8C76-4DBA-8357-0FBC5C158788Q30382468-7217DBBA-9F91-414D-8676-14470F1022AFQ33589580-A8F431DA-1CA4-422C-BBAA-9BB73F6753F7Q33819123-4D89F941-FEF3-419F-8736-BC3B509B63FBQ34037765-C2CDD2A3-2E7A-42D7-A351-B70D19A8E181Q34687429-EE0D38C2-CBCC-4D94-B8F3-AFF39D5D4ED7Q34794290-A101BEB2-FAC9-44F4-843C-97E87D863D18Q35202543-C6477268-9916-4C8F-B3A0-2D5C3109342AQ35204894-ABC86031-7579-4F56-8F3F-F62FF7302179Q35591547-6C033478-A52D-4A90-BC80-A507C9C5B44EQ35768775-C65D1053-A4B7-4BEE-A678-34E6D5E4B965Q36446863-9770DA15-486E-4DC6-8CCB-2060BDBFCC41Q36495180-74530E7B-0491-4C82-AD09-02D7B519F76EQ36575384-36FAC246-36E1-49CF-A0E5-F583A2CCCBF7Q36582240-EB8883F4-02C8-478B-8EBB-A65AE735C5A1Q36607260-D966BBFE-9480-4883-A77C-327EA28C901EQ36799413-E39F8C4F-6E75-4319-A45A-5C060F1777C3Q36848133-6759AB34-AA5C-47FF-9372-9DDDD6C9EC63Q36900171-E236C282-3C72-4B5B-A9E8-36E1BA104108Q37178976-F10A174C-EE4A-4970-96E2-24C80C8A5C1BQ37374171-E7E1D15F-AEDB-482E-99F6-7A4E1010B9A8Q37625940-D2760136-53C8-4486-B9F3-545339276AF4Q38206345-10CFEF3A-0662-4FE2-A022-B2779A271157Q39045957-AE064F37-9441-4166-BCD2-FB3720813395Q39494122-42A142C6-BABC-48D0-A573-1E6C7BDC3F6DQ39636655-175E14E8-3082-482F-9235-F74604147334Q40081579-762B7B2B-5CDF-4D2F-9E11-59698AF2D872Q40177012-3776F5E8-C8E6-41A4-87CB-85311FD46B57Q40392781-EE7C12AE-871D-490F-A263-A674F5423AB8Q40961889-94454A0D-2429-460D-9311-9FDAE1F5AF18Q41858660-FADF1E98-166C-45A4-A307-B6184C8B3031Q42380848-6B2F1D66-0601-4F7A-8EF7-DE28EA25A88AQ42749859-42654789-D39D-40E4-A99B-8F8D26DA8809Q44894391-5A02B5B8-56B5-48A9-9B7A-FE59950F1305Q44916902-C18CEDF4-F5A9-4727-AE93-ADE52F362F98Q46887646-01895FCF-4F84-4D60-BEB7-1A3B86C429D7
P2860
Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment -- a review.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Working memory deficits after ...... cts for treatment -- a review.
@ast
Working memory deficits after ...... cts for treatment -- a review.
@en
type
label
Working memory deficits after ...... cts for treatment -- a review.
@ast
Working memory deficits after ...... cts for treatment -- a review.
@en
prefLabel
Working memory deficits after ...... cts for treatment -- a review.
@ast
Working memory deficits after ...... cts for treatment -- a review.
@en
P2093
P2860
P1433
P1476
Working memory deficits after ...... cts for treatment -- a review.
@en
P2093
Laura A Flashman
Molly B Sparling
Thomas W McAllister
P2860
P304
P356
10.1080/02699050310001617370
P577
2004-04-01T00:00:00Z